Hoxton Planning & Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Sell
913
-21
-2% -$7.19K 0.09% 166
2026
Q1
$329K Buy
934
+10
+1% +$3.56K 0.1% 150
2025
Q4
$302K Buy
924
+3
+0.3% +$952 0.09% 156
2025
Q3
$260K Sell
921
-79
-8% -$22.9K 0.08% 171
2025
Q2
$279K Buy
1,000
+32
+3% +$9.06K 0.1% 163
2025
Q1
$302K Buy
968
+20
+2% +$5.91K 0.12% 149
2024
Q4
$247K Sell
948
-50
-5% -$14.8K 0.09% 176
2024
Q3
$321K Buy
998
+262
+36% +$85.7K 0.12% 147
2024
Q2
$230K Sell
736
-3
-0.4% -$881 0.11% 142
2024
Q1
$210K Buy
739
+40
+6% +$11.7K 0.1% 155
2023
Q4
$201K Buy
+699
New +$190K 0.11% 144
2023
Q2
Sell
-1,076
Closed -$260K 145
2023
Q1
$260K Buy
1,076
+86
+9% +$21.1K 0.14% 128
2022
Q4
$260K Buy
+990
New +$265K 0.14% 132

Other funds holding AMGN

Hoxton Planning & Management's AMGN Position: Q2 2026 in Review

Hoxton Planning & Management reduced its Amgen (AMGN) stake by 2.2% in Q2 2026, selling an estimated $7.19K and leaving 913 shares worth $331K. The position accounts for 0.09% of the portfolio, ranked #166.

Hoxton Planning & Management first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. 728 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hoxton Planning & Management held 913 shares of Amgen worth $331K as of Q2 2026.
  • Hoxton Planning & Management sold 21 Amgen shares in Q2 2026, an estimated $7.19K.
  • Amgen made up 0.09% of Hoxton Planning & Management's portfolio in Q2 2026, its #166 holding.
  • Hoxton Planning & Management first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
  • 728 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hoxton Planning & Management's 13F filing for Q2 2026, filed 16 Jul 2026.